Courtney Shea - Concepedia

Author

Courtney Shea

Ironwood Pharmaceuticals (United States)

Also Known As

C Shea, C. Shea, COURTNEY SHEA, Courtney M. Shea, Courtney Shea, Jenny Tobin

Publications

702

Citations

H-Index

Concepts

All Affiliations

Ironwood Pharmaceuticals (United States)Cyclerion (United States)

About

Courtney Shea is an author at Ironwood Pharmaceuticals (United States) specializing in inflammation, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	133
2	Immunology	3	3	106
3	Health Sciences	2	2	63
4	Allergy	1	1	42
5	Diabetes	1	1	27

Courtney Shea

Publications

665

Citations

H-Index

Page 1

	Year	Citations
Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate Joel Castro, Andrea M. Harrington, Patrick A. Hughes, Gastroenterology	2013	285
The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis Roger Flores‐Costa, José Alcaraz‐Quiles, Esther Titos, British Journal of Pharmacology	2017	74
Gastrointestinal pain: Unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation Inmaculada Silos‐Santiago, Gerhard Hannig, Hélène Eutamène, Pain	2013	69
Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease Jenny Tobin, Daniel P. Zimmer, Courtney Shea, Journal of Pharmacology and Experimental Therapeutics	2018	59
Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo Sheila Ranganath, Ashok Bhandari, Nicole Avitahl-Curtis, PLoS ONE ImmunologyKda Polyethylene GlycolNeutralizing ActivityImmunologic MechanismImmunotherapy	2015	42
Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure Courtney Shea, Gavrielle M. Price, Guang Liu, American Journal of Physiology-Renal Physiology HypertensionHeart FailureNitric OxideImmunologyCardiovascular Pharmacology	2019	36
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease Daniel P. Zimmer, Courtney Shea, Jenny Tobin, Frontiers in Pharmacology	2020	33
Inhibition of human neutrophil chemotaxis by corticosteroids. Courtney Shea, Morse Ed PubMed InflammationHuman Neutrophil ChemotaxisAlter MotilityDirect Inhibitory EffectAnti-inflammatory	1978	28
Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells Guang Liu, Courtney Shea, Juli E. Jones, American Journal of Physiology-Renal Physiology Suppresses InflammationRenal PathologyRenal InflammationCell DeathBlood Pressure	2020	27
SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet Virginia Reverte, Francisca Rodríguez, Lidia Oltra, American Journal of Physiology-Heart and Circulatory Physiology	2022	12

Page 1